"SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia"
written by Fatih M. Uckun, Sanjive Qazi,
published by Journal of Cancer Therapy, Vol.5 No.1, 2014
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] National Cancer Institute Alliance for nanotechnology in cancer—Catalyzing research and translation toward novel cancer diagnostics and therapeutics
2019
[2] Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays
Oncotarget, 2018
[3] Spleen tyrosine kinase (SYK) protects renal tubular epithelial cell against hypoxia injury in children with acute kidney injury
Gene, 2018
[4] Role of Protein Kinases and Their Inhibitors in Radiation Response of Tumor Cells
Current Pharmaceutical Design, 2017
[5] Syk inhibitors in clinical development for hematological malignancies
2017
[6] An in vivo RNAi therapy screen identifies novel mediators of leukemia-microenvironment interaction
2017
[7] Вплив інгібітора протеїнкіназ похідного малеіміду на морфофункціональний стан мишачих лейкемічних клітин L1210
В?сник Льв?вського ун?верситету. Сер?я б?олог?чна , 2016
[8] Therapeutic Approaches to Drug Targets in Leukemia
Int J Ayu Pharm Chem, 2016
[9] Recent advances and novel treatment paradigms in acute lymphocytic leukemia
2016
[10] Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3
Oncotarget, 2016
[11] Lipid Phosphatases and Oxidative Signalling in T Lymphocytes
2015
[12] A Woman With CD19-Positive, B-Cell ALL
2015
[13] Response to tyrosine kinase inhibitors in a transplantable mouse model of BCR-ABL1+ BCP-ALL
2015
[14] Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia
Journal of cellular and molecular medicine, 2015
[15] 21: Leveraging Structure-Based Rational Drug Design and Nanotechnology to Destroy Leukemic Stem Cells
Stem Cells, 2015
[16] Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia
Haematologica, 2015
[17] The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
Leukemia, 2015
[18] Somatic copy number losses on chromosome 9q21. 33q22. 33 encompassing the PTCH1 loci associated with cardiac fibroma
Cancer genetics, 2015
[19] Appendix: Response to tyrosine kinase inhibitors in a transplantable mouse model of BCR-ABL1+ BCP-ALL
Signature redacted, 2015
[20] Precursor B-cell acute lymphoblastic leukemia and the problem ofminimal residual disease
2015
[21] Lipid Phosphatases and Oxidative Signalling in T Lymphocyte Biology
2015
[22] Somatic copy number losses on chromosome 9q21.33q22.33 encompassing the PTCH1 loci associated with cardiac fibroma
Cancer Genetics, 2015
[23] Leveraging Structure-Based Rational Drug Design and Nanotechnology to Destroy Leukemic Stem Cells
Stem Cells, Tissue Engineering and Regenerative Medicine, 2014